Introduction
The current biopsy protocol routinely used by urologists is the transrectal ultrasound (TRUS) guided systematic sextant biopsy. 1 However, this protocol results in a positive detection rate of only 20 ± 30%. 2, 3 Furthermore, a signi®cant number of patients (20 ± 40%) with elevated prostate speci®c antigen (PSA) have a positive repeat biopsy, suggesting that many patients with prostate cancer are not being diagnosed initially using the sextant protocol. 4 ± 7 Recent clinical studies have suggested that the sextant technique may not be optimal and have investigated new biopsy protocols that may yield signi®-cantly better results. 8 ± 10 Recently, studies using computer simulation of prostate biopsies have been published suggesting that additional biopsies can increase the sensitivity of the procedure. Both two-dimensional (2-D) and three-dimensional (3-D) computer-based simulations of prostate cancer have been shown to be useful in evaluating existing biopsy protocols. 11 ± 14 Our group recently published data based upon 3-D computer reconstructed models of step-sectioned whole-mounted radical prostatectomy specimens. This simulated data suggests that laterally placed prostate biopsies in addition to the traditional sextant biopsy pattern increased the cancer detection rate by 26.4%. 15 The objective of our study was to determine if these additional lateral biopsies used in the simulated 10-core prostate biopsy pattern results in a higher prostate cancer detection rate in actual patients.
Methods

Clinical data
Between January 1997 and January 1999, 35 consecutive patients diagnosed with prostate cancer by a single urologist (JJB) using a 10-core biopsy pattern (sextants and four additional lateral biopsies at the apex and mid gland) were evaluated. The various regions of the prostate were sampled in a similar manner in all 35 patients. Biopsies were performed in the right and left apex, mid and base regions of the prostate (sextant protocol) in planar angle half-way between the midline and the lateral edge of the prostate. Additional biopsies in the lateral aspect of the right and left apex and mid regions were obtained in a planar angle midway between the sextant biopsy locations and the lateral border of the prostate (lateral biopsies). These regional biopsies were chosen based upon our simulated biopsy results which are similar to the ®ve-region biopsy pattern suggested by Eskew et al 9 less the midline biopsies and the lateral base biopsies. The tip of the needle was brought up to the capsule of the prostate at a 30 angle. The capsule was deformed under direct ultrasound visualization, the needle was retracted until the capsule regained its original shape and then the needle was discharged. It is extremely important that the needle not be seated in the prostate before the biopsy is taken. Unpublished data from our interactive 3-D simulated prostate biopsy system showed that the majority of tumors were located very close to the capsule. If the needle is seated in the prostate prior to biopsy a signi®cant number of tumors may be missed using this technique.
Data analysis
Frequencies of positive biopsies in the various prostate regions were determined. The mean positive biopsy hits were calculated for each biopsy protocol. Table 1 is a summary of the individual positive biopsy frequencies for each region of the prostate. The average positive frequency rate for a sextant biopsy core was 19.0% (40 positive/210 cores), whereas the average positive frequency rate for the lateral prostate biopsies was 32.9% (46 positive/140 cores). The two highest frequencies were noted in the left lateral apex and left lateral mid regions Ð 45.7% and 40.0% respectively.
Results
The overall detection rate for the sextant pattern was 54.3% (19/35). The sextant biopsies detected cancer in ®ve of 35 patients (14.3%) when the lateral biopsies were negative. The lateral biopsies detected cancer in 16 of 35 patients (45.7%) when the sextant biopsy cores were negative. The overall positive cancer detection rate for just the four laterally placed biopsies was 85.7% (30/35).
Discussion
Our previously published study using 3-D reconstructed prostate models supports the routine use of laterally placed biopsies. 15 This pilot clinical study con®rms that the 10-core prostate biopsy pattern, which includes laterally placed biopsies, is superior to the traditional sextant biopsy pattern commonly used by most urologists. When comparing the sextant and the 10-core prostate biopsy patterns in the 35 patients, the traditional sextant biopsy pattern had a cancer detection rate of 54.3% (19/35) . In our previous evaluation of multiple biopsy patterns using 3-D reconstructed prostate models, a four-core biopsy pattern which included only the lateral biopsies (right and left lateral apex and lateral mid regions) approximated the detection rates of the biopsy protocols that used 10, 12, 14 or 16 cores (93.5% vs 99.0%, 99.0%, 99.5%, 100%, respectively). In this clinical trial, the four-core lateral biopsy pattern also had a superior prostate cancer detection rate when compared to the sextant pattern (85.7% vs 54.3%). This data exempli®es the importance of the lateral prostate biopsies in the detection of prostate cancer using systematic patterns. It is also very important that the biopsies are obtained along the posterior and lateral surface of the prostate. The majority of tumors in our 3-D reconstructed radical prostatectomy specimens were located near the posterior and lateral capsule. If one positions the needle into the prostate 15 Current screening tests for prostate cancer include PSA and digital rectal exam (DRE). The combination of these two tests and a more informed patient and physician population has led to an increased number of prostate needle biopsies. However, with a 20 ± 30% detection rate the accuracy of currently used biopsy techniques needs to be improved. There are also a signi®cant number of prostate cancers that are detected on repeat biopsies. Keetch et al, 5 reported a 24% (104/427) positive repeat biopsy rate in men with persistently elevated PSA after initial negative biopsy. Lui et al 16 reported a higher repeat positive biopsy rate of 38% (72/187). Lui's study additionally identi®ed that 28% (53/187) of the repeat biopsies had cancers detected in the peripheral zone and 10% (19/187) in the transitional zone. When Ukimura et al 17 evaluated 226 men that had undergone repeat biopsies for an elevated PSA, 51 men (26%) were found to have prostate cancer on repeat biopsy. Cancer was found in 17% (33/193) of all men on the ®rst repeat biopsy and 26% (14/54) of patients who underwent a second repeat biopsy. Repeat biopsy has potential morbidity and contributes signi®cantly to the costs of detecting prostate cancers. With such a high incidence of positive repeat biopsies many other techniques have been evaluated to determine the patient that would have a higer probability of a repeat positive biopsy. Currently, the ratio of free-tototal PSA for patients with a PSA value between 4 and 10 ng/ml is increasingly being used to determine the risk of prostate cancer after an initial negative biopsy. 4, 18 Our group showed that a percentage free PSA less than or equal to 10% was highly predictive of cancer after prior negative biopsy showing a 91% speci®city and 86% speci®city. 18 Daneshgari et al, 11 developed a 2-D computer simulation of the prostate based on 159 radical prostatectomy specimens. The computer then generated random prostates and tumors. This computer model was used to simulate the sextant biopsy protocol and verify its ability to detect low-volume tumors. Various biases for the angle of biopsy and distribution of cancer foci were incorporated in the model. The simulation showed that only 20.3% of the simulated prostates had a tumor distribution in which sextant biopsy had a 95% probability of tumor detection. In fact, 26.8% of prostates had a distribution that was completely disjointed from the sextant locations. These prior ®ndings show that a signi®cant number of patients who have prostate cancer are not diagnosed at their initial biopsy. Accordingly, improving the predictive value of TRUS guided biopsy by optimizing biopsy protocols will improve its value as a diagnostic tool and the value of PSA itself.
A number of researchers have investigated techniques for improving the accuracy of biopsy protocols; however, several issues remain to be resolved. Eskew et al introduced a new protocol called the ®ve-region biopsy in which additional lateral and midline biopsies are added systematically to the traditional sextant biopsy. 9 The ®ve-region biopsy and the traditional sextant biopsy were compared in 119 patients who underwent transrectal ultrasound guided needle biopsy of the prostate. In 48 cancer patients, 17 (35%) were detected only by the additional needles of the ®ve-region biopsy method. As a result, the new ®ve-region biopsy method was claimed to improve biopsy results. Eskew's results are promising, but the study group of 48 patients was small. Therefore, this protocol needs to be validated, and the underlying rationale for using 13 needles instead of some other number should be examined. Our group also found that the ®ve-region protocol showed a statistically signi®cant advantage over the sextant method based on 89 patients with cancer. 13 Chang et al, 10 also showed that lateral biopsies increase the sensitivity of prostate cancer detection. Fourteen percent of 118 patients had prostate cancer detected by only the lateral prostate biopsies. Dietrick et al conducted a clinical study of 110 men who underwent radical prostatectomy and compared the core cancer length with the volumes of clinically signi®cant and incidental carcinoma. 19 For sextant biopsies, Dietrick determined that an optimal biopsy core length of 3 mm or more could reliably detect cancer of clinically signi®-cant volume. Vashi et al developed a statistical model that determined the optimal number of biopsies to achieve a 90% certainty of detecting various volumes of life threatening cancer. 20 This model incorporated the variables of tumor doubling time, age and prostate volume. Patients with prostate volumes greater than 20 g and aged 50 ± 69 y required an increased number of biopsies (7 ± 23 biopsies) to detect life threatening prostate cancers. Goto et al suggested that new biopsy strategies could be developed based on probability maps of cancer distribution within the prostate. 8 However, issues such as how these maps should be built and how new biopsy protocols could be derived from the maps remain to be investigated.
Recently, the use of 3-D computer simulation has supported the use of lateral biopsies as an essential component in any protocol to increase the detection rate of prostate cancer. Karakiewicz et al, using a 3-D computer-assisted analysis of sector biopsies, showed that, as they increased the number of biopsies from four to 12 and incorporated lateral zone biopsies, the detection rates increased. 14 This was especially true for the larger volume prostates. Chen et al and Kaplan et al both used 3-D computer simulations of prostate biopsy based upon reconstructed radical prostatectomy specimens. 12, 13 Both studies showed that the sextant protocol was less sensitive ( 20%) than biopsy patterns that used an increased number of cores and laterally placed biopsies. Finally, our group recently published similar data supporting the use of laterally placed biopsies in over 200 3-D reconstructed whole-mounted step-sectioned radical prostatectomy specimens. The prostate biopsy patterns that included lateral prostate biopsies had cancer detection rates that were between 17.9 and 27.4% higher than the traditional sextant biopsy pattern. 15 Most recently, Presti et al, 21 Babaian et al 22 and Naughton et al 23 have con®rmed the value of laterally directed prostate biopsies in separate investigations.
Conclusions
Our group's previous 3-D reconstruction of radical prostatectomy specimens with spatial anatomy that included the capsule, surgical margins and tumors showed that the majority of the tumors were near the posterior-lateral surface of the prostate. The laterally placed biopsies in the posterior-mid and posterior-apex regions of the gland resulted in the highest positive biopsy frequencies. The 10-pattern biopsy protocol provided the highest relative detection rate for the number of biopsies performed during a single procedure. Our pilot study con®rms that the 10-pattern biopsy protocol is superior to the traditional sextant pattern in detecting adenocarcinoma of the prostate.
